Publication:
Clinical significance of HER2 overexpression in gastric and gastro-esophageal junction cancers: Is there any discordance between IHC and FISH

Simple item page
dc.contributor.authorsBaykara, M.; Benekli, M.; Ekinci, O.; Irkkan, C.; Demirci, U.; Karaca, H.; Unal, O. U.; Dane, F.; Akinci, B.; Turkoz, F. P.
dc.date.accessioned2022-03-12T16:14:25Z
dc.date.accessioned2026-01-11T14:07:26Z
dc.date.available2022-03-12T16:14:25Z
dc.date.issued2013
dc.identifier.doidoiWOS:000326843603566
dc.identifier.eissn1879-0852
dc.identifier.issn0959-8049
dc.identifier.urihttps://hdl.handle.net/11424/225349
dc.identifier.wosWOS:000326843603566
dc.language.isoeng
dc.publisherELSEVIER SCI LTD
dc.relation.ispartofEUROPEAN JOURNAL OF CANCER
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleClinical significance of HER2 overexpression in gastric and gastro-esophageal junction cancers: Is there any discordance between IHC and FISH
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS595
oaire.citation.startPageS595
oaire.citation.titleEUROPEAN JOURNAL OF CANCER
oaire.citation.volume49

Files

Collections

Araştırma Çıktıları